News Coverage

Dr Miriam Laker-Oketta, a Medical doctor and Clinical Research Scientist at the Infectious Diseases Institute has been selected by the International Women’s Forum (IWF) to be part of the 2020-2021 Fellows Program. She is the first fellow from East and Central Africa to be awarded.
Dr Aggrey S. Semeere a physician and researcher with IDI has been appointed as a Principle Investigator at the East African International Databases to Evaluate AIDS (IeDEA-EA),one of seven regional data centres funded by the U.S. National Institutes of Health to provide a rich resource for globally diverse HIV/AIDS data.
The Executive Director, Dr Andrew Kambugu and Dr Mohammed Lamorde head of the Global Health Security programme met with the Hon. State Minister for Animal Husbandry Bright Rwamirana and the Permanent Secretary Mr Pius Wakabi Kasaija at the Ministry of Agriculture, Animal Industries and Fisheries offices in Entebbe.
It is estimated that 5 of every 10 TB patients in the Karamoja region completes treatment successfully and only 3 of 10 get cured. This region of 9 districts and an estimated population of 1.2million was declared by the Ministry of Health as having one of the highest TB burdens in Uganda.
The IDI-led consortium -CAPA-CT II, funded by @EDCTP program published a method for measuring quantity of experimental drug for #COVID19 in patient blood samples. This team is the first to openly publish a method for quantifying remdesivir in blood.
The Executive Director Dr Andrew Kambugu has been named on the scientific group for the UN 2021 Food Systems Summit. The search committee sought African voices from disciplines related to food systems.
IDI joined Rakai Health Services Program, an IDI implementing partner as a partner in the region and has since mentored 651 VHTs in COVID-19 surveillance for Rakai and Kyotera.
Scottish clinical and scientific experts are spearheading a campaign to bust myths and combat misinformation in the battle against Covid-19 in Uganda.
The Centres of Disease Control (CDC) in collaboration with Infectious Diseases Institute (IDI) channelled out its efforts towards building local capacity in Kasese district in the production and distribution of Alcohol Based Hand Sanitizer (ABHS) as a means of improving hand hygiene practices as an Ebola preparedness strategy.
Every year the world commemorates World TB Day on March 24th, the day in 1882 when Dr. Robert Koch announced the discovery of the bacterium that causes Tuberculosis (TB).
Kampala, Uganda | THE INDEPENDENT | The Ministry of Health under its Case Management structure has started training of the Uganda People’s Defence Forces (UPDT) on the COVID-19 pandemic.
The Infectious Diseases Institute (IDI) Global Health Security Programme (GHSP) and Health Systems Strengthening E-AMAKA project organized a three-day Infection Prevention and Control training for 20 Voluntary Medical Male Circumcisers (VMMCs).
With support from Resolve To Save Lives, the Executive Director of the Infectious Diseases Institute (IDI), Dr. Andrew Kambugu today, Friday 13th March, 2020 handed over equipment worth UGX310 Million to the Ministry of Health (MoH) to prevent, detect and respond to public health threats at Points of Entry (PoE).
Over 80 countries have been affected by the Corona Virus across the globe and the case fatality is currently at 3.4%. Many myths and assumptions about the virus have circulated in public, which has caused panic. In case of an outbreak, are we ready to respond?
Infectious Diseases Institute has been commended for its passion, unconditional commitment and dedicated service towards pharmacovigilance. Pharmacovigilance is the monitoring of the effects of medical drugs after they have been licensed for use, especially in order to identify and evaluate previously unreported adverse reactions. This award was handed over at the launch of the MedSafety App at the 3rd Annual Pharmacovigilance Stakeholders Round-table Meeting held at Golf Course Hotel on 26th February 2020.
Uganda has received three pioneering laboratory machines to speed up the process of testing and treating patients for bacterial infections as part of the Fleming Fund Country Grant, which is aimed at helping low and middle income countries tackle antimicrobial resistance (AMR). The machines automate part of the laboratory tests that identify the bacteria causing a patient’s infection and can deliver results to doctors up to 18 hours quicker, saving critical time in the diagnosis of life-threatening conditions.
On 3rd December 2019, Infectious Diseases Institute through the Dolphin 2 study team participated in an exhibition during the 20th International Conference on AIDS & STIs in Africa, Kigali – Rwanda Convention Centre. This was under the theme “Understanding the Safe and effective use of Dolutegravir for mothers (and their babies) who present with untreated HIV in late pregnancy”. The exhibition aimed at dissemination of quantitative and qualitative results for DolPHIN 2 study and to create awareness about DolPHIN 2 study.
On 20th August 2019, the Prime Minister of Uganda officiated at the launch of the NAPHS 2019 – 2023 under the slogan “Securing Uganda Against Health Threats”. The plan comes in to address the gaps identified during the Joint External Evaluation (JEE) conducted in June 2017, in compliance with the International Health Regulations (IHR), 2005. The event was graced by several high level dignitaries including Hon. Dr. Jane Ruth Aceng.
NTI | bio, in partnership with the Next Generation Global Health Security Network, announced the winners of the 2018 Next Generation for Biosecurity Competition. Peter Babigumira Ahabwe of the Infectious Diseases Institute, Uganda along with two others [Dr. Frances Butcher, Oxford School of Public Health, UK and Javier Rodriguez, National Commission of Atomic Energy, Argentina] were named winners of a 15,000 USD grant. Their proposal, “Act Like a Pro: Scenario-Based eLearning for the Next Generation of Biosecurity Learners,” is an openly accessible online platform for students and entry-level professionals to engage in scenario based learning in biosecurity.

Esther was an Afya Bora fellow in Global Health leadership 2017/18. The Afya bora Consortium which was conceived to train health professionals in leadership, consists of nine universities in Africa, the Unites states of America and China.

To its already rich pool of courses, IDI is excited to announce new Quality Management Systems courses (QMS) for laboratory personnel, namely

The management of the Infectious Diseases Institute (IDI) has raised a concern to the Ministry of Health about unscrupulous individuals intending to discredit the work of IDI in the field of HIV and AIDS programming. This is occurring in a context where IDI management recently instituted a criminal investigation (CRB – 323/2018) against two former employees.

Congratulations to Dr. Mohammed Lamorde on his new executive role at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) as Chair of Africa Network.

ISPOR is the leading professional society for health economics and outcomes research (HEOR) globally. The ISPOR Africa Network is a group within the organizational structure of ISPOR that consists of ISPOR regional chapters from different countries in Africa. It also constitutes approximately 5000 academics, researchers and industry experts.

Researchers from the University helped to deliver a free training course in Uganda this month (18 – 20 April 2018) for students and researchers from or based in developing countries to help in the management of poverty-related diseases.

The VirTUAL Consortium (Vulnerable patient Tuberculosis AntiretroviraL), which is led by the University’s Institute of Translational Medicine, is an international initiative to optimise the safe and effective treatments of poverty related diseases including HIV and TB using a combination of clinical trials, pharmacokinetic modelling and capacity building approaches. Together this aims to improve current understanding of drug disposition in complex clinical scenarios and provide a flexible platform for identifying clinical strategies with application to other disease areas.

This year’s UNAIDS Global AIDS report- “Miles to go” noted that the number of AIDS-related deaths was lowest this century, with fewer than 1 million people dying each year from AIDS-related illnesses.
This is in part a result of sustained access to antiretroviral therapy which has seen a record 21.7 million people enroll on treatment. In order to sustain these significant gains, the report calls for scale up of access to treatment by global institutions working towards an AIDS-free world.
On a hot sunny Saturday morning on March 24, 2018, district officials and implementing partners in Arua district kicked off the celebrations commemorating World Tuberculosis & Leprosy day with a five kilometer run and thereafter converged at Booma grounds. Opening remarks were made by the Deputy mayor of Arua Kalusum Abdul who welcomed all stakeholders and partners with special thanks to the guest of honor Honorable Sarah Opendi, the State Minister for Health and General Duties.

At the regional follow up event during the Presidential Fast track initiative(PFTI) celebrations held in Hoima at the end of February 2018; Dr. Lisa Nelson the Ugandan CDC country Director in her speech was impressed by the level of HIV services coverage in the region. She thanked the Government and IDI a key implementing partner for offering comprehensive HIV care and treatment in the region.

On October 3, 2017 in Johannesburg South Africa, the European & Developing Countries Clinical Trials Partnership (EDCTP) launched an Alumni network whose goal is to foster Excellence and Collaboration in the next generation of researchers.

IDI supports ART differentiated service delivery models to improve client retention in care

To support the continuous assessment and tracking of medicine supply chain management, the Ministry of Health (MOH) with support from Uganda Health Supply Chain (UHSC) project established a system known as Support Supervision Performance Assessment and Recognition Strategy (SPARS). As an implementing Partner, IDI is mandated to support the MOH Medicine Management Supervisors (MMS) to execute the health facility assessments across Masindi and Kiryandongo districts using the SPARS tool.

In the second last week of November, the Infectious Diseases Institute (IDI) welcomed the Ugandan Country Director for the Centers for Disease Control and Prevention (CDC), Dr. Lisa Nelson to the West Nile region where IDI is currently implementing the Comprehensive HIV/AIDS service delivery project, which also covers South Sudan refugees and a One-Health Global Health Security Project (GHSP).

On June 28 in Masindi district and on June 29, 2017 in Hoima district, the Infectious Diseases Institute (IDI) organized and held the second Annual Performance Review meeting for its Western Region Comprehensive HIV/AIDS project funded by the Centres for Disease Control and Prevention (CDC).